Oracle Financial Services Software Limited Open Interest & PCR Analysis
₹10,777Updated 22 Jul 2026, 03:30 pm IST
PCR
0.52
Bearish signal
Max Pain
₹11,200
Spot below by ₹423
Total CE OI
1.46M
Call writers
Total PE OI
763K
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish
Data as of 2026-07-22
Related Analysis
Frequently Asked Questions
What is Oracle Financial Services Software Limited PCR (Put-Call Ratio) today?▾
Oracle Financial Services Software Limited's current PCR is 0.52. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Oracle Financial Services Software Limited's PCR of 0.52 indicates bearish sentiment.
What is Oracle Financial Services Software Limited OI buildup type today?▾
Oracle Financial Services Software Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Oracle Financial Services Software Limited?▾
Oracle Financial Services Software Limited has total CE (call) OI of 1457200 contracts and total PE (put) OI of 763300 contracts for the nearest expiry. The PCR is 0.52.
How is open interest analysis useful for Oracle Financial Services Software Limited trading?▾
OI analysis for Oracle Financial Services Software Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Oracle Financial Services Software Limited?▾
Oracle Financial Services Software Limited's max pain is ₹11,200 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.